Patents

US 12084418 B2: Small molecule inhibitors of G(alpha)i2 protein and uses thereof

Granted
2024-09-10
Filed
2021-12-20 application 17556820
Type
Utility · 6 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The disclosure relates to novel compounds and methods of use of the compounds to maintain the Gαi2 protein in its inactive GDP-bound state. The disclosure describes the knockdown or inhibition of Gαi2 negatively regulated migration of breast and ovarian cancer cell lines. The novel compounds inhibit the migratory behavior of PC3, DU145 and E006AA prostate cancer cell lines. Specifically, the novel compounds block the activation of Gαi2 in oxytocin-stimulated prostate cancer PC3 cells and inhibits the migratory capability of DU145 cells overexpressing constitutively active form of Gαi2, under basal and EGF-stimulated conditions.

Source: PVGPATDIS, file of 2026-04-10 (ipg240910.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
CLARK ATLANTA UNIVERSITY, INC. 5 patentsUS company or organizationAtlanta, GACLARK ATLANTA UNIVERSITY INC Nonprofit EXACT high confidence: identical full name and state
Clark Atlanta University College or university FUZZY medium confidence: same name (governing-board words and legal endings aside) and state
CLARK ATLANTA UNIVERSITY Federal lobbying client FUZZY medium confidence: same name (legal endings aside) and state
PVGPATDIS, file of 2026-04-10
GEORGIA TECH RESEARCH CORPORATION 1,417 patentsUS company or organizationAtlanta, GAGEORGIA TECH RESEARCH CORPORATION State business registration EXACT high confidence: identical full name and state
GEORGIA TECH RESEARCH CORPORATION Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Shafiq A. KhanMableton, GA1PVGPATDIS, file of 2026-04-10
Silvia CaggiaDecatur, GA1PVGPATDIS, file of 2026-04-10
Adegboyega K. OyelereMarietta, GA12PVGPATDIS, file of 2026-04-10
Subhasish TapadarAtlanta, GA6PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PVGPATDIS, file of 2026-04-10
C07DHeterocyclic compoundsC07D209/36PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2024-06-25Assignment
Assignment of assignor's interest
OYELERE, ADEGBOYEGA K. signed 2024-06-13
TAPADAR, SUBHASISH signed 2024-06-14
GEORGIA TECH RESEARCH CORPORATION ATLANTA, GA67836/42ECORSEXC, file of 2026-09-25
2024-06-25Assignment
Assignment of assignor's interest
CAGGIA, SILVIA signed 2023-10-09
KHAN, SHAFIQ A. signed 2023-10-09
CLARK ATLANTA UNIVERSITY, INC. ATLANTA, GA67836/1ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.